title: Possible hepatosplenic candidiasis treated with liposomal amphotericin B and caspofungin combination.
authors.forename: Bilgin
authors.initials: B
authors.lastname: Arda
authors.forename: Nur
authors.initials: N
authors.lastname: Soyer
authors.forename: Oguz Resat
authors.initials: OR
authors.lastname: Sipahi
authors.forename: Ozcan
authors.initials: O
authors.lastname: Hüdaverdi
authors.forename: Meltem Isikgoz
authors.initials: MI
authors.lastname: Tasbakan
authors.forename: Guray
authors.initials: G
authors.lastname: Saydam
authors.forename: Murat
authors.initials: M
authors.lastname: Tombuloglu
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy*; D000077336:Caspofungin; D054714:Echinocandins; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D055666:Lipopeptides; D008107:Liver Diseases / Q000382:microbiology*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013158:Splenic Diseases / Q000382:microbiology*
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; C068538:liposomal amphotericin B; D000666:Amphotericin B; D000077336:Caspofungin